Login

CAREL Industries Spa's Officer aims to analyze the company's sales strategies, processes, and methodologies. 00:10:00

Share On Facebook Share On Twitter

Francesco Nalini, CAREL Group CEO.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
About what raising capital means|Alex Gurevich,Managing Director,Javelin Venture Partners
00:10:00
Exploring Disruption in Banking Technology: Goh Peng Ooi's Insights from Finzsoft HQ | Goh Peng Ooi , Founder, Silverlake Axis Ltd.
00:10:00
Rede Liquidity Index 2H 2022: Key Market Insights | Gabrielle Joseph - Head of Due Diligence & Client Development, Rede Partners
00:10:00
Planning for College: Patti Hughes on Discussing Student Loans with Your Child | Patti Hughe, Principal , Lake Life Wealth Advisory Group LLC.
00:10:00
Presentation on Ariana Resources: Gold Exploration, Development, and Production in Turkey
00:10:00
Transforming the companies we acquire|Ramzi Musallam,CEO,Veritas Capital
00:10:00
Emmanuel Roman Discusses Pimco's Strategy and Market Outlook |  Emmanuel Roman, CEO, PIMCO.
00:10:00
Initiator Pharma A/S, a biotech company based in Århus, Denmark, focuses on developing the drug candidate IPED2015.
00:10:00
Guy Hands Discusses Future of Alternative Investments and Global Challenges | Guy Hands, Chairman, Terra Firma Capital Partners.
00:10:00
Importance of Diversifying Custodians for Asset Management
00:10:00
Altamira Gold's Michael Explores Brazilian Gold and Copper Prospects and Strategic Growth at One-to-One Conference
00:10:00
Care deeply about the next generation of local entrepreneurs.|Ari Newman,Partner, The Fund Rockies,The Fund

© 2017 - Neuhu+